| MeSH | D000077423 |
| PubChem Compound | 24750 |
| ChEBI | 31765 78770 |
| CHEMBL | CHEMBL1201751 |
| KEGG | dr:D01539 dr:D01993 |
| ZINC | 8437287 |
| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | Dizziness | FAERS: 4 | US FAERS | |
| 2 | Nausea | FAERS: 3 | US FAERS | |
| 3 | Pallor | FAERS: 3 | US FAERS | |
| 4 | Pulmonary Embolism | FAERS: 3 | US FAERS | |
| 5 | Cardiac Arrest | FAERS: 2 | US FAERS | |
| 6 | Cerebrovascular accident | FAERS: 2 | US FAERS | |
| 7 | Drug ineffective | FAERS: 2 | US FAERS | |
| 8 | Epilepsy | FAERS: 2 | US FAERS | |
| 9 | Gangrene | FAERS: 2 | US FAERS | |
| 10 | Headache | FAERS: 2 | US FAERS | |
| 11 | Migraine with Aura | FAERS: 2 | US FAERS | |
| 12 | Peripheral arterial reocclusion | FAERS: 2 | US FAERS | |
| 13 | Psychomotor skills impaired | FAERS: 2 | US FAERS | |
| 14 | Syncope | FAERS: 2 | US FAERS | |
| 15 | Thrombophlebitis | FAERS: 2 | US FAERS | |
| 16 | Abdominal Pain | FAERS: 1 | US FAERS | |
| 17 | Agitation | FAERS: 1 | US FAERS | |
| 18 | Amnesia | FAERS: 1 | US FAERS | |
| 19 | Amnestic Disorder | FAERS: 1 | US FAERS | |
| 20 | Anaphylactic shock | FAERS: 1 | US FAERS | |
| 21 | Angioedema | FAERS: 1 | US FAERS | |
| 22 | Application site vesicles | FAERS: 1 | US FAERS | |
| 23 | Asthenia | FAERS: 1 | US FAERS | |
| 24 | Burning sensation | FAERS: 1 | US FAERS | |
| 25 | Connective tissue inflammation | FAERS: 1 | US FAERS | |
| 26 | Cyanosis | FAERS: 1 | US FAERS | |
| 27 | Depressed Level of Consciousness | FAERS: 1 | US FAERS | |
| 28 | Disorientation | FAERS: 1 | US FAERS | |
| 29 | Drug exposure during pregnancy | FAERS: 1 | US FAERS | |
| 30 | Duodenal perforation | FAERS: 1 | US FAERS | |
| 31 | Dysphemia | FAERS: 1 | US FAERS | |
| 32 | Epistaxis | FAERS: 1 | US FAERS | |
| 33 | Erythema | FAERS: 1 | US FAERS | |
| 34 | Fibrin D dimer increased | FAERS: 1 | US FAERS | |
| 35 | Infusion site erythema | FAERS: 1 | US FAERS | |
| 36 | Injection site cellulitis | FAERS: 1 | US FAERS | |
| 37 | Injection site inflammation | FAERS: 1 | US FAERS | |
| 38 | Injection site necrosis | FAERS: 1 | US FAERS | |
| 39 | Injection site pain | FAERS: 1 | US FAERS | |
| 40 | Injection site warmth | FAERS: 1 | US FAERS | |
| 41 | Lymphangitis | FAERS: 1 | US FAERS | |
| 42 | Necrosis | FAERS: 1 | US FAERS | |
| 43 | Osteomyelitis | FAERS: 1 | US FAERS | |
| 44 | Pancreatitis | FAERS: 1 | US FAERS | |
| 45 | Paraplegia | FAERS: 1 | US FAERS | |
| 46 | Pelvic venous thrombosis | FAERS: 1 | US FAERS | |
| 47 | Post procedural complication | FAERS: 1 | US FAERS | |
| 48 | Pruritus | FAERS: 1 | US FAERS | |
| 49 | Respiratory distress | FAERS: 1 | US FAERS | |
| 50 | Tremor | FAERS: 1 | US FAERS | |
| 51 | Ulcer | FAERS: 1 | US FAERS | |
| 52 | Venous Thrombosis | FAERS: 1 | US FAERS | |
| 53 | Venous stenosis | FAERS: 1 | US FAERS | |
| 54 | Visual Impairment | FAERS: 1 | US FAERS |
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120235
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.